SC Quashes Substandard Rabeprazole Case Against Indica Labs, Cites Limitation Bar Susmita Roy24 Sept 2025 7:06 PM ISTNew Delhi: The Supreme Court of India has set aside criminal proceedings initiated against directors of Indica Laboratories Pvt. Ltd., holding that...
Allahabad HC Flags Procedural Flaws, Quashes Drugs Case Summons Against Pharma Firm Susmita Roy23 Sept 2025 8:18 PM ISTNew Delhi: The Allahabad High Court has quashed the summoning order issued against Associated Biotech and its directors in a drugs (Amoxycillin)...
Spurious Drugs Alert: Diazepam, PAN 40, and PAN-D Capsules Under Investigation Susmita Roy22 Sept 2025 4:46 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has raised alarms over three batches of critical medicines, including anti-anxiety...
94 Drug, Medical Product Batches Fail CDSCO Quality Tests in August Susmita Roy21 Sept 2025 3:30 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has identified 94 batches of medicines and medical products as "Not of Standard...
Allahabad HC Grants Relief to Pharma Firm Against Tax Notices Susmita Roy20 Sept 2025 10:38 PM ISTNew Delhi: The Allahabad High Court has quashed orders passed against Safecon Lifescience, holding that proceedings under Section 74 of the GST Act...
Box Warning, Dose Limits: India Set To Tighten Nimesulide Use Susmita Roy19 Sept 2025 5:29 PM ISTNew Delhi: The Central Government has instructed pharmaceutical companies to include a prominent "Box Warning" on the widely used painkiller...
Novartis Loses India Patent on Heart Failure Drug Vymada Susmita Roy18 Sept 2025 4:00 PM ISTNew Delhi: In a major setback for Swiss drugmaker Novartis, the Indian Patent Office (IPO) has cancelled the patent for its heart failure drug Vymada...
Cocrystals of Approved APIs to Be Treated as New Drugs, Clarifies CDSCO Susmita Roy17 Sept 2025 5:22 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a clarification...
NPPA Fixes Retail Prices of 9 Formulations Including Dapagliflozin, Sitagliptin, Aceclofenac FDCs, Details Susmita Roy16 Sept 2025 2:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Keeping Medicines Without Licence Amounts to 'Offer for Sale', HC Upholds Chemist's Conviction Susmita Roy15 Sept 2025 8:42 PM ISTShimla: The Himachal Pradesh High Court has upheld the conviction of a chemist under the Drugs and Cosmetics Act, 1940, for stocking allopathic...
Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute Susmita Roy14 Sept 2025 2:00 PM ISTNew Delhi: In a relief to Sun Pharma Laboratories Limited, the Bombay High Court has granted an interim injunction restraining Rambos Lifesciences...
AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause Notice Parthika Patel13 Sept 2025 8:24 PM ISTNew Delhi: AstraZeneca Pharma India Limited has received a show cause notice from the National Pharmaceutical Pricing Authority (NPPA), which has...
